AlleleNews -- for in between experiments
Click "Links" to find Product Group Pages on Allele Biotech home
Monday, 01.22.2018, 05:06pm (GMT-7)
  Home
  Events
  FAQ
  RSS
  Links
  Site Map
  Contact
 
GET TO KNOW YOUR NEIGHBOR ; SDEE 2015 Year End Social on Dec 8th in San Diego ; Must Attend 5-Day Event in San Diego Starting Tomorrow! -- CDW on Cells, Sensors, and Sysems, with Updates on Stem Cells ; SDEE October 2015 Event - Financings: Tales from the Tranches ; Allele Biotech Takes Major Step into Nano Antibody Leadership Position
::| Keyword:       [Advance Search]
 
All News  
  All science fields
  News Release from Allele and Associated Organizations
  Using single cell technologies for functional studies
  Job Postings/Lab Visits/Vendor Shows
  Imaging, Structure, and Optogenetics
  Brain and Neuron Development
  Camelid Antibodies
  FP Technologies and In Vivo Imaging
  iPSC MSC ESC Differentiation
  Immune systems, T cell Therapy, stem cell therapy
  RNA, RNAi, and miRNA Updates
  NexGen Sequencing, Epigenetics, and Editing
  News Release from Other Organizations
  ::| Poll
How do you social? Pick your TOP (#1) pick!
Facebook
Twitter
GooglePlus
WeChat
LinkedIn
Myspace
Youtube
 
  ::| Newsletter
Your Name:
Your Email:
 
 
 
News Release from Other Organizations
 
Knome launches first platform-agnostic human genome sequencing and analysis service for researchers
Wednesday, 12.02.2009, 10:00am (GMT-7)

CAMBRIDGE, Mass., November 18, 2009 – Knome, Inc., a recognized pioneer in the personal genomics field, today announced the launch of KnomeDISCOVERY, the first fully integrated human genome sequencing and data processing service for researchers. The new offering meets rapidly emerging demand from biomedical researchers for a one-stop service that bundles affordable, research-tailored access to a broad range of next-generation sequencing platforms with discovery-supportive data management and analysis. KnomeDISCOVERY is expected to catalyze important genetic insights into rare and common human diseases, and to accelerate the development of effective treatments.


In 2007, only three complete human genomes were available for research. In 2010, by contrast, Knome expects to see the sequencing of thousands of genomes as government and private foundations invest hundreds of millions of dollars in grants to leverage the empirical power of individual genome sequencing.


As the cost of sequencing drops, and the tide of genome data rises, data management and analysis are emerging as pressure points that require significant computational infrastructure and expertise. Through KnomeDISCOVERY, individual research groups can leverage Knome’s unparalleled sequencing platform access and experience in whole genome and exome analysis.


The new service is ideal for two types of researchers:

  • Researchers with expertise in medical genomics who want to streamline data management and preliminary analysis in forthcoming mass sequencing projects – Leveraging high-volume access to sequencing platforms, Knome handles the logistical hurdles of rapid-turnaround sequencing, and carries out the important but computationally intensive process of “background” genome analysis, freeing researchers to focus on specific question-driven hypothesis testing that can yield novel discoveries in genetic medicine; and

  • Clinically trained researchers with extensive expertise in specific diseases, for whom mass sequencing approaches are novel and unfamiliar tools – Knome’s expertise in analyzing whole genome data can directly help these researchers pinpoint novel alleles that contribute to a disease of interest. Knome takes a “fine-toothed” approach to genomic data analysis, grounded in a thorough understanding of genome structure and function; protein biochemistry; population/evolutionary genetics; statistical analysis; and basic disease etiology, as refined by close consultation with the researcher. This approach can quickly identify potentially disease-relevant candidate alleles for researchers to consider for follow-up empirical assessment.

“This is a pivotal moment for genetic research, as the pace of novel genotype-phenotype discovery accelerates,” said Jorge Conde, CEO of Knome. “Scientists understand the value of whole-genome and exome sequencing, but few have requisite access to the full complement of state-of-the-art sequencing machinery, data management systems and bioinformatics expertise. Having sequenced and analyzed the genomes of more individuals than any company in the world, Knome is now offering the research community a fast and cost-efficient way to move from DNA to discovery.”


Knome works with researchers to create solutions tailored to their scientific aims, as well as their budget, timing and volume requirements. Pricing for KnomeDISCOVERY starts at less than $12,000 per sample, depending on desired sequence coverage and degree of custom consultation required, with turn-around in as little as eight weeks.


Knome’s bioinformaticians use kGAP, the company’s proprietary analysis platform, to deliver a thorough accounting of both novel and previously known sequence variants. Knome’s analysis includes annotation of published allele-disease associations, as well as sophisticated prediction of potential functional effects of newly discovered variants, helping guide researchers to regions of the genome that are potentially relevant to a disease of interest.


“We are excited to bring the scientific research community the type of genome sequencing and data analysis services that have previously only been available to a small number of individuals at large institutions,” said George Church, Professor of Genetics at Harvard Medical School and co-founder of Knome. “It is our hope that by making these types of services broadly accessible to many more scientists, the process of discovery will be greatly accelerated.”


About Knome, Inc.

Based in Cambridge, Mass., Knome is a leading human genomics company focused on providing secure, state-of-the-art sequencing, data management, and analysis solutions to researchers and individuals. Knome was the first company to offer complete genome (KnomeCOMPLETE) and exome (KnomeSELECT) sequencing and analysis services. Led by internationally-recognized geneticists, clinicians and bioinformaticians, Knome has been responsible for sequencing and interpreting more human genomes than any other company in the world. For more information, please visit www.knome.com.



Media Contacts:
For Knome
Shira Frantzich
Sterling Communications, Inc.
408-884-5156
press@knome.com

For Technology Review
Kate Casolaro
617-312-4964
press@technologyreview.com
AlleleNews Service

Comments (0)        Print        Tell friend        Top


Related Articles:
» Laboratory, Research/ Development
» Identification of active transcriptional regulatory elements from GRO-seq data
» Focus on epilepsy
» Technology Transfer for Startups--How to maximize value by working with the tech transfer office
» All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins
» Writing an NIH/SBIR Grant Intensive Workshop for Entrepreneurs--Thursday, July 10, 2014, 5:30pm – 8:30pm
» MDA5 and autoimmune disease
» Time-lapse X-ray phase-contrast microtomography for in vivo imaging and analysis of morphogenesis
» SDEE Co-Sponsoring Janssen Labs Event Dec 17–Trends in Financing
» [Report] Observing the Dynamics of Dipole-Mediated Energy Transport by Interaction Enhanced Imaging
» Building San Diego Biotech Event October 28 2013: Incubate, Communicate, Collaborate
» SABPA Event Tomorrow: Paving the Path to Success
» Biotech Employment Skills Training 2013 San Diego
» Proteomics: marked for depth
» Allele Sponsors SABPA Event at UCSD on March 23rd
» Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells
» Phase modulation at the few-photon level for weak-nonlinearity-based quantum computing
» Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury
» Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts
» Manipulation of cellular light from green fluorescent protein by a femtosecond laser
» How does p53 control cellular response to stress in different ways?
» Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
» A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
» RNAi patent win
» Urocortin 3 as marker for mature beta cells
» Spatiotemporal control of gene expression by a light-switchable transgene system
» GPR-120 is a faulty fat sensor, as shown in mouse model and confirmed in human sequencing data
» Changes in stem cells--a comprehensive analysis
» Weight regain after weight loss linked to special alleles
» An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells
» Localization imaging with standard fluorescent proteins on live cells—Bayesian modeling
» On-chip optical isolation in monolithically integrated non-reciprocal optical resonators
» An Activating Mutation of AKT2 and Human Hypoglycemia
» Super-resolution 3D microscopy of live whole cells using structured illumination
» How to get NIH/SBIR Grants Intensive Workshop for Entrepreneurs
» Starting and Supporting a Business with Grants
» Epigenetic Licensing of Germline Gene Expression by Maternal RNA in C. elegans
» Looking at pathway, not just SNPs
» Functional mapping of single spines in cortical neurons in vivo
» New from Yamanaka lab: "Master transcription factor" Glis1 promotes reprogramming
» Identification of clustering artifacts in photoactivated localization microscopy
» Whole-genome sequencing identifies recurrent mutations in chronic lymphocyticleukaemia
» SDEE Quarterly Event: Serial Entrepreneurship--Success and Failure
» Human neurons can be directly generated from somatic cells.
» Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells
» A roadmap to generate renewable protein binders to the human proteome
» Fast, three-dimensional super-resolution imaging of live cells
» See Allele's Sales Managers for Deals at Scripps Tuesday 05/10
» Designing the Next Generation of Chemical Separation Membranes
» How the core RNAi pathway is regulated throughout the cell cycle
» Next-generation sequencing to generate interactome datasets
» Focus on stem cells
» 5/7/2011 (Sat): Japan Earthquake Relief Garage Sale (a charity rummage sale)
» Chemically defined conditions for human iPSC derivation and culture
» Cheap fluorescent microscope for M. tuberculosis detection
» A natural antagonist of TNFa with implications in treating arthritis
» Considerations for Qualifying a CMO to Manufacture your [Biologic] Product for FIH
» A bioinformatic assay for pluripotency in human cells by Müller et al.
» Mapping of signaling networks through synthetic genetic interaction analysis by RNAi
» Confined activation and subdiffractive localization enables whole-cell PALM with genetically expressed probes
» Drosophila Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression patterns
» Something new under the skin
» A microprobe for parallel optical and electrical recordings from single neurons in vivo
» Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
» Warming up to a glow
» Use of Light-Activated Cation Channel Channelrhodopsin-2 to Study Heart Pace Maker Cells
» Cost Effective Antibiotic Honey Screening – A ‘Sweet Investment’
» Scientists have found more than 30 new gene variations linked to obesity
» Hormone profiling from Randox provides quality results
» The long road: peering into live cells (some with photoswitchable FPs)
» Liquid ready to use controls ideal for Point-of-Care (POC) testing
» SDEE Oct 13th Event: Intellectual Property and Licensing
» Improved patient profiling with Randox Metabolic Syndrome Arrays
» House's Appropriations Committee’s health spending subcommittee's 2011 NIH NSF budgets
» MicroRNA-132 is identified as a stimulator of neovascularization
» Hello SDSU
» GFP-Trap Successfully Used in Plants and Other Systems
» Witness the launch of Evidence Evolution at AACC
» Fruitless chirping in the night
» Whole mouse organs imaged in 3D Using Self Fluorescence
» Entrepreneurs Roundtable: How to Get Seed Funding
» More Naïve State of Human iPSCs?
» From Nature Biotechnology: SBIR grants wax
» Great Introduction of Allele Services at LIAI
» Buy Randox Laboratories products online NOW!
» SCRIPPS INSTITUTION OF OCEANOGRAPHY, UC SAN DIEGO Vendor Show
» Breakfast Vendor Show at UCSD and Free Lunch for a Lab Today
» SDEE Entrepreneurs Roundtable - How to Get Government Grants: The Insider’s View
» Biochip Array Technology – the future of Biomarker detection!
» NIH Announces SHIFT SBIR Grants to Help Academic Researchers Get Jobs in Biotech
» Breast Cancer Gene Patents Invalidated
» Rebuilding a windpipe with own stemcells
» Wnt/b-Catenin important for stem cells responsible for leukemia, but not needed in normal hematopoietic stem cells (HSC).
» Randox maternal screening control sera - Confidence when it’s needed most
» Blood vessels may be a new niche for stem cells
» Three types of skin cells can all come from one type of stem cells in the follicles
» New Randox Life Science Website up and running!
» MicroRNAs: From Decay to Decoy, and beyond
» News Release from Randox--NEW Liquid quality control sera available now
» iPS patent issues in the spotlight
» Analyzing miRNA, microarray vs next-gen sequencing, our own perspectives
» Silicon Nanowires to Penetrate Cell Membrane for TransfectionSilicon Nanowires to Penetrate Cell Membrane for Transfection
» Two affinity peptides linked as high affinity binders as “Synbody”
» Genome-wide association study (GWAS) of metabolic traits identified metabolically relevant enzymes or carriers.
» Nature Method's review on iPSCs and lists Allele Biotech as a supplier
» Drug based on RNAi targets tumor progression shows effects in bladder and liver cancer
» Reprogrammable mice created by a single insertion of polycistonic iPS factors
» New RNAi delivery technology demonstrates higher efficacy and decreased dosage requirements
» Baculovirus used to make flu vaccines in insect cells
» Magnetic nanoparticle tag used on detection antibody increase ELISA sensitvity
» Vitamine C stimulates reprogramming
» New dyes to make STED more widely used
» Injecting Stem Cells Into Brains
» Medical advances that sound like science fiction
» Making long RNA strands in warm water-mimicking reactions on primordial earth
» beta-globin control region and promoter-driven fluorescent protein used to monitor stem cell differentiation
» Using the right dose of ultrasound can increase tumor marker release
» How does Avastin compare to Herceptin in curing breast cancer?
» Real-Time PCR dye
» Knockout screens using haploid human cells
» Lung cancer proteins may be cancer markers
» Sequence 100 human genomes in 10 days for under $10,000 per genome
» Rapid drugs of abuse screening from Randox
» BioTechnique: Recent papers advance GFP knowledge
» Your News Release Here
» Is US science the best in the world in the public eye?
» By Using Formaldehyde Crosslinking, Chromatins Found to Pack into Functional Compartments
» Dual Activation for Tighter Control of Induced Gene Expression
» Nobel Prize in Chemistry Goes to Researchers on Ribosome
» Nobel Prize in Physics on fiber optics and CCD digital sensor
» Intracellularly Expressed Camelid Single-Domain Antibody (VHH) Counteracts Cytotoxicity Seen in Agricultural Epidemics
» Breakfast at ACADIA Pharmaceuticals went very well
» Difference between hESCs and NSC-Derived Integration-Free iPSCs
» RNAi Has Been Found in Budding Yeast
» Stem cells found as origin for prostate cancer
» How to use photoconvertible fluorescent proteins to trace dynamic subcellular structures
» How many mutations you may have?
» Publication by Allele Scientists: A Tale of Twin Functions
» Sep 1st Vendor Show at Pac Hall
» RNAi machinery interacts with specialized chromatin component in regulating antisense RNAs
» iPSC generated by using a single reprogramming factor, Oct4…with limitations?
» Proof-of-Principle Validation that iPSCs are Functional Equivalent to ES Cells?
» Deoxyribozymes found to cut single-stranded DNA
» Making iPSC easier to create by suppressing p53
» Lab Visits: Please email us to schedule lab visits in your area.
» VHH from camelid antibodies can be found against integral membrane proteins


Other Articles:
Rapid drugs of abuse screening from Randox (11.24.2009)
Your News Release Here (11.05.2009)
Virtual Trade Show for the Pharma & Life Science Industries (11.05.2009)



 
  ::| Events
January 2018  
Su Mo Tu We Th Fr Sa
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
 
::| Hot News
What You Need To Know About Term Sheets for Early Stage Financing and Partnering Intensive Workshop for Entrepreneurs
SDBN September 22 2014 Networking Town Hall With 52nd District Congressman Scott Peters
OBR Event in San Diego April 16, at 6:00pm
A Quiet Revolution: The Reinvention of Clinical Trials, from Omics to mHealth
SDEE Quarterly Event at La Jolla Janssen Labs on Alternative Funding Strategies: How to Start and Grow Your Company
mRNA-iPSCs, Nanobodies, and Superresolution Imaging—In Clinical Trials and R&D
San Diego Entrepreneurs Exchange Sep 2013 Newsletter
This House Believes Genes Should be Patented
Don't miss the SABPA Family Picnic 8/11, that is this Sunday!
U.S. Senate Panel Gives NIH $31 Billion in 2014, $2 Billion More Than 2013